Supplementary PE Progress Test

This page provides data visualizations related to the priorities for Canada’s cancer system, as well as accessible descriptions.

Download data tables for all indicators.


Priority 1 Action 1: Help people to stop smoking or not start in the first place and live healthier lives

Topic: Keeping people smoke-free
Title of image: Percentage of individuals in PE (aged ≥ 12) classified as daily or occasional smokers in 2019
Caveats/limitations:

  • This indicator was reported using the Canadian Community Health Survey (CCHS). Overall smoking rates are reported using 2019 data.
  • Individuals who did not respond to the required CCHS questions regarding smoking status were not included in the analysis.
  • The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.

16.2% for Prince Edward Island, and 14.7% for Canada


V2 PE P1 A1 Smoking Progress EN – Jan 25 


New PE P1 A1 Smoking Sex Progress EN

Topic: Keeping people smoke-free
Title of image: Percentage of individuals in PE (aged ≥ 12) classified as daily or occasional smokers, by sex (TBC)
Caveats/limitations:

  • Interpret with caution owing to large variability in the estimate for females in 2021 (Pandemic era).
  • The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.


Data source: Canadian Community Health Survey


Topic: Keeping people smoke-free
Title of image: Percentage of individuals in PE (aged ≥ 18) classified as daily or occasional smokers in 2019, by household income quintile and sex
Caveats/limitations: The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey. Interpret with caution owing to large variability in the estimates for 2021 data points (Pandemic era).
Lowest quintile: males:21.5%, females: 9.5%. Highest quintile: males: 11.7%, females: 22.5%. Full table to follow. width=

PE P1 Act1 Smoking Income Progress EN – Updated Jan 25

 

Data source: Canadian Community Health Survey


Topic: Keeping people smoke-free
Title of image: Percentage of individuals in PE (aged ≥ 18) classified as daily or occasional smokers in 2019, by highest level of education
Caveats/limitations: The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey. Interpret with caution owing to large variability in the estimates for less than secondary and secondary school graduation for 2021 (Pandemic era).
Less than secondary school: females: 21.7%; males: 37.6%. Secondary school graduation, no post-secondary education: females: 19.6%; males: 20.7%. Diploma or university degree: females: 11.6%; males: 13.5%</li> <p>

PE P1 Act1 Smoking education Progress EN

 

Data source: Canadian Community Health Survey



Topic: Maintaining healthy body weight
Title of image: Percentage of individuals in PE (aged ≥ 18) classified as overweight or obese in 2019
Caveats/limitations: The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.
bar graph

V2 PE P1 Act1 Obese Overall Progress EN – Jan 25

V3 PE P1 Act1 Obese Overall Progress EN updated Feb 3

Data source: Canadian Community Health Survey


Topic: Maintaining healthy body weight
Title of image: Percentage of individuals in PE (aged ≥ 18) classified as overweight or obese in 2017-2018, by income quintile and sex
Caveats/limitations: The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.
Lower quintile: females: 69.2%; males: 66.2%. Upper quintile: females: 65.3%; males: 84.7%. Full table to follow.

V2 PE P1 Act1 Obese Male Sex Income Progress EN – updated by Kavitha earlier 

Revised male image not found by Catherine on Jan 26

Topic: Maintaining healthy body weight
Title of image: Percentage of males in PE (aged ≥ 18) classified as overweight or obese, by income quintile
Caveats/limitations: The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey

V2 PE P1 Act1 Obese Male Sex Income Progress EN Feb 3

 


New PE P1 Act1 Obese Female Sex Income Progress EN

Data source: Canadian Community Health Survey


Topic: Maintaining healthy body weight
Title of image: Percentage of individuals in PE (aged ≥ 18) classified as overweight or obese in 2017-2018, by sex
Caveats/limitations: The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.
78.5% for males, and 67.0% for females

V2 PE P1 Act1 Obese overall Sex Progress EN – updated by Catherine on Jan 27 – is year OK?

Data source: Canadian Community Health Survey


Priority 1 Action 2: Adopt proven practices known to reduce the risk of cancer

Topic: Increasing HPV vaccination
Title of image: Percentage of students aged 12-22 completely vaccinated* for HPV in PE in 2019.
*Complete vaccination = Three doses for ages 12+ before 2015. From 2015, only two doses = Complete vaccination
Caveats/limitations: The COVID-19 pandemic may have affected service provision.
Age 12: Males, 82.1%. Age 12: Females, 84%.
NEW P1 Act2 Indic1a HPV Vaccine 2020 – Jan 25


Topic: Increasing HPV vaccination
Title of image: Percentage of males aged 12-18 completely vaccinated* for HPV in PE.
*Complete vaccination = Three doses for ages 12+ before 2015. From 2015, only two doses = Complete vaccination
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

PE P2 Act2 HPV Vaccine Male Sex Progress EN – updated Jan 25

 


Topic: Increasing HPV vaccination
Title of image: Percentage of females aged 12-18 completely vaccinated* for HPV in PE.
*Complete vaccination = Three doses for ages 12+ before 2015. From 2015, only two doses = Complete vaccination
Caveats/limitations: The COVID-19 pandemic may have affected service provision.


V2 PE P2 Act2 HPV Vaccine Female Sex Progress EN – updated Jan 25

V3 PE P1 Act2 HPV Vaccine Female Sex Progress EN Feb 3


Data source: Provincial cancer agencies and programs



Topic: Increasing genetic testing
Title of image: Percentage of PE patients with breast, colorectal and ovarian cancer who received genetic testing in 2019
Caveats/limitations:

  • Close to half of women with ovarian cancer received genetic testing compared to almost 13% of women with breast cancer. This could be explained as all women with ovarian cancer are eligible for genetic testing while only a subgroup of women with breast cancer are eligible for genetic testing according to the guidelines for genetic testing.
  • Only 5% of people with colon cancer received genetic testing. Similarly, only a subcategory of people with colon cancer are eligible for genetic testing.
    Breast 12.9%. Colorectal 5.1%. Ovarian 46.7%.

Data source: Provincial cancer agencies and program


Priority 2 Action 1: Prioritize rapid access to appropriate diagnosis for those suspected of having cancer

Topic: Reducing wait for diagnosis
Title of image: Wait time (days) from suspicion of breast cancer to time of diagnosis in PE (year of diagnosis: 2019)
Caveats/limitations:

  • For women who had more than one cancer diagnosed in the year, only the earliest cancer was kept.
  • The COVID-19 pandemic may have affected service provision.

Mean: 33. Median: 22.5. 90th Percentile: 70.

PE P2 Act1 Suspicion to diagnosis Progress EN – updated Jan 25

Data source: Provincial cancer agencies and programs



Topic: Diagnosing cancer earlier
Title of image: Proportion of stage 4 or later stage cancer diagnosis in PE in 2018
Caveats/limitations: The COVID-19 pandemic may have affected service provision.
52.7% for lung; 23.2% for colorectal; 19.6% for bladder (Stage 2 to 4 combined); 17.5% for melanoma (Stage 3 to 4 combined)

V2 PE P2 Act1 Stage IV Progress EN updated Jan 25 – is the year 2019 correct?

V3 PE-P2-Act1-Stage-IV-Progress-EN Feb 3

Data source: Provincial cancer agencies and programs


Priority 2 Action 2: Strengthen existing screening efforts and implement lung cancer screening programs across the country

Topic: Increasing participation in colorectal cancer screening
Title of image: Percentage of people in PE that had a FIT test in the past 2.5 years (Jul 1, 2017 – Dec 31, 2019) or had a sigmoidoscopy or colonoscopy in the past 10 years (Jan 1, 2010 – Dec 31, 2019)
Caveats/limitations: The COVID-19 pandemic may have affected service provision.
Overall (Age 50 to 74): 59.9%. Age 50 to 54: 56.7%. Age 55 to 59: 54.6%. Age 60 to 64: 59.9%. Age 65 to 69: 66.9%. Age 70 to 74: 63.4%

Data source: Provincial cancer agencies and programs


Priority 3 Action 1: Set best practices and standards for care delivery and promote their adoption

Topic: Implementing multidisciplinary care
Title of image: Percentage of pediatric patients in PE not treated in the adult cancer treatment centre who were discussed at the multidisciplinary discussions in 2019
Caveats/limitations: The COVID-19 pandemic may have affected service provision.
Overall: 100%

V1 PE P3 Act1 Pediatric Progress EN – updated by Kavitha earlier

V2 PE P3 Act1 Pediatric Progress EN – updated by Catherine on Jan 27

Data source: Provincial cancer agencies and programs


Topic: Implementing multidisciplinary care
Title of image: Percentage of adult patients with rectal cancer in PE discussed at multidisciplinary rounds or discussions in 2019
Caveats/limitations: The COVID-19 pandemic may have affected service provision.
Overall: 33.3%

PE P3 Act1 Rectal Progress EN – moved to this spot on Jan 25

Data source: Provincial cancer agencies and programs


Priority 3 Action 2: Eliminate low-benefit practices and adopt high-value practices

Topic: Optimizing care at end of life
Title of image: Percentage of patients with cancer who received systemic therapy in the last two weeks of life in 2019
Overall: 3.6%
Data source: Provincial cancer agencies and programs

No new visual recd.


Topic: Optimizing care at end of life
Title of image: Percentage of patients with cancer who received systemic therapy in the last two weeks of life in 2019, by treatment type, cancer type, and age at death
Caveats/limitations:
Lung cancer patients and those patients less than 70 years old were more likely to receive systemic therapy than those non-lung cancer or older patients.
Denominator is all deaths among patients with cancer, not specifically deaths due to cancer.
96.4% received no treatment. Full table to follow.

 

 

No new visual recd.


Data source
: Provincial cancer agencies and programs


Topic: Optimizing screening and appropriate follow-up
Title of image: Percentage of individuals in PE who had a second screen 11-18 months after first screen in 2018 (breast cancer by frequency)

Overall (Age 50 to 74): 33.4%. Age 50 to 59: 30.4%. Age 60 to 69: 35.3%. Age 70 to 74: 35.6%

No new visual recd.

Data source: Provincial cancer agencies and programs


Topic: Optimizing screening and appropriate follow-up
Title of image: Percentage of people with a cervix in PE aged 18-24 who were screened with Pap test in 2017-19
Caveats/limitations: Individuals with cervical cancer or hysterectomies were not excluded.
Overall (18-24): 42.1%. Age 18 to 20: 12.1%. Age 21 to 24: 63.4%

No new visual recd.

Data source: Provincial cancer agencies and programs


Priority 3 Action 3: Design and implement new models of care

Topic: Expanding models of care
Title of image: Percentage of current or recent tobacco users who participated in a Tobacco Cessation program in the cancer treatment centre after receiving a referral to the program in 2021
Caveats/limitations:

  • Over half of cancer patients who were current tobacco users were enrolled in the Tobacco Cessation Program at the ambulatory cancer treatment centre.
  • A higher proportion of lung cancer patients enrolled in the Tobacco Cessation Program than all other cancer patients.
  • The COVID-19 pandemic may have affected service provision.

Total tobacco users: 46.7%. Recent tobacco users: 21.4%. Current tobacco users: 52.5%.

Topic: Expanding models of care
Title of image: Percentage of total, current or recent tobacco users who participated in a Tobacco Cessation Program after receiving a referral to the program in 2021/22, by age group
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

V2 PE P3 A3 MOC Tobacco use Progress EN updated by Catherine Jan 26

Note: *Suppressed owing to small numbers.
Data source: Provincial cancer agencies and programs

V3 PE-P3-A3-MOC-Tobacco-use-Progress-EN Feb 3

Note: *Suppressed owing to small numbers.
Data source: Provincial cancer agencies and programs


Topic: Expanding models of care
Title of image: Percentage of current or recent tobacco users who participated in a Tobacco Cessation Program after receiving a referral to the program in 2021, by age group, sex, and cancer type
Caveats/limitations:

  • Females were more likely than males to accept a referral to the Tobacco Cessation Program.
  • The COVID-19 pandemic may have affected service provision.

Females were more likely than males to accept a referral to the Smoking Cessation Program. Full table to follow.

V1 New PE P3 A3 MOC Age Tobacco Total, Recent, Current use Progress EN

Topic: Expanding models of care
Title of image: Percentage of total, current or recent tobacco users who participated in a Tobacco Cessation Program after receiving a referral to the program in 2021/22, by age group
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

V2 PE P3 A3 MOC Age Tobacco Total, Recent, Current use Progress EN – updated Jan 25 – 2021/22 

*Suppressed owing to small numbers. 

V1 PE P3 A3 MOC Sex Tobacco Total, Recent, Current use Progress EN – updated by Kavitha earlier

 

Topic: Expanding models of care
Title of image: Percentage of total, current or recent tobacco users who participated in a Tobacco Cessation Program after receiving a referral to the program in 2021/22, by sex
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

V2 PE P3 A3 MOC Sex Tobacco Total, Recent, Current use Progress EN – updated by Catherine on Jan 26

*Suppressed owing to small numbers. Also, the COVID-19 pandemic may have affected service provision.


V1 PE P3 A3 MOC Type Tobacco Total, Recent, Current use Progress EN – updated by Kavitha earlier

Topic: Expanding models of care
Title of image: Percentage of total, current or recent tobacco users who participated in a Tobacco Cessation Program after receiving a referral to the program in 2021/22, by cancer type
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

V2 PE P3 A3 MOC Type Tobacco Total, Recent, Current use Progress EN – updated by Catherine Jan 26

*Suppressed owing to small numbers. Also, the COVID-19 pandemic may have affected service provision.
Data source: Provincial cancer agencies and programs

Priority 4 Action 1: Provide better services and care adapted to the specific needs of underserved groups

Topic: Increasing access to culturally safe care
Title of image: TBC
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

Brand new PE-P3-Act1-Respect-EN – moved on Jan 26

 

Data source: Patient satisfaction survey


Priority 4 Action 2: Ensure rural and remote communities have the resources required to better serve their people

Topic: Increasing access to virtual care
Title of image: Percentage of patients with cancer who had virtual appointments in 2019
Caveats/limitations:

  • All the virtual out of province appointments conducted with PEI cancer patients participating at a PEI hospital were measured. It was difficult to recognize if the appointment was for treatment or for diagnosis.
  • The COVID-19 pandemic may have affected service provision.

Overall: 0.6%

 

New PE P4 Act2 Virtual Care Progress EN

Data source: Provincial cancer agencies and programs


Topic: Increasing access to virtual care
Title of image: Percentage of patients with cancer who had virtual appointments, by sex
Caveats/limitations: The COVID-19 pandemic may have affected service provision.
Male 0.4%. Female 0.7%.

V1 PE P4 Act2 Virtual Care Sex Progress EN

V2 PE P4 Act2 Virtual Care Sex Progress EN Feb 3

*Suppressed owing to small numbers. 


Topic: Increasing access to virtual care
Title of image: Percentage of patients with cancer who had virtual appointments, by age
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

V2 PE P4 Act2 Virtual Care Age Progress EN – updated by Catherine Jan 26

V3 PE P4 Act2 Virtual Care Age Progress EN Feb3

Note: *Suppressed owing to small numbers.


Topic: Increasing access to virtual care
Title of image: Percentage of patients with cancer who had virtual appointments, by residence
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

New PE P4 Act2 Virtual Care Residency Progress EN – updated by Kavitha earlier

V2 PE P4 Act2 Virtual Care Residency Progress EN – updated by Catherine on Jan 26

Data source: Provincial cancer agencies and programs


Priority 4 Action 3: Ensure care can be delivered between provinces, territories and federal jurisdictions when needed

Topic: Improving access to timely care for people who need to travel between jurisdictions
Title of image: Average wait time (in days) for patients with cancer who require cancer treatment outside of their home jurisdiction in 2019

Caveats/limitations:

  • The average wait time for cancer patients who require cancer treatment outside of their home jurisdiction was about one and a half months (47 days).
  • Half of the cancer patients waited about one month (34 days) to have their virtual appointments.
  • The highest average wait time for cancer patients was among cancer patients aged less than 50.
  • Regarding the cancer site, prostate cancer patients represented the highest percentage of cancer patients who had virtual appointments for treatment and had an average wait time of 43 days.
  • Patients who had their referral request date after the treatment date (due to delayed referral request) were excluded from the analysis.
  • Sometimes, it is not clear if the referral was for diagnostic procedure or for treatment; hence if the date of referral was before the date of diagnosis, it was likely for diagnostic purposes.
  • Some wait times were extended because the patients were receiving preparatory treatment in the form of chemotherapy or radiotherapy before their out of province appointment.
  • The COVID-19 pandemic may have affected service provision.

Median is 34 days, mean is 47 days

 

V1 PE P4 Act3 Wait Time Treatment Progress EN – updated by Kavitha earlier

V2 PE P4 Act3 Wait Time Treatment Progress EN – updated by Catherine on Jan 26

Note: – Data not available. 
Data source: Provincial cancer agencies and programs


Topic: Improving access to timely care for people who need to travel between jurisdictions
Title of image: Average wait time (in days) for patients with cancer who require cancer treatment outside of their home jurisdiction in 2019, by sex and age group

 

Mean is 45 days for males and 51 days for females. Median is 34 days for males and 31 days for females. Full table to follow.

Topic: Improving access to timely care for people who need to travel between jurisdictions 
Title of image: Wait time (in days) for patients with cancer who require cancer treatment outside of their home jurisdiction, by sex
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

PE P4 Act3 Wait Time Sex Progress EN Feb 3

Note: – Data not available.

V1 PE P4 Act3 Wait Time Age Mean Progress EN – updated by Kavitha earlier

V2 PE Act3 Wait Time Age Progress EN – updated by Catherine on Jan 26 – very different though 


V1 PE P4 Act3 Wait Time Age Median Progress EN – updated by Kavitha earlier


V2 PE Act3 Wait Time Age Progress EN – updated by Catherine on Jan 26 – very different though


Data source: Provincial cancer agencies and programs



Topic: Improving access to transportation and general support for those needing to travel between jurisdictions
Title of image: Percentage of all PE patients with cancer with out of province appointments who were awarded transportation support in bus tickets, bridge or ferry passes, and plane tickets in 2019
Caveats/limitations:

  • The denominator included all patients in the cancer registry with an out-of-province appointments with cancer diagnoses. The exact reason(s) the patient went to this appointment cannot be checked so it was assumed that it was for cancer diagnosis or treatment.
  • There are other transportation supports for cancer patients provided by the Canadian Cancer Society (CCS) in Prince Edward Island according to the eligibility criteria of the CCS. This helps in reducing the burden of transportation needs.
  • The COVID-19 pandemic may have affected service provision.

Hope Air: 29.5%. Maritime bus: 1.8%

V2 PE P4 Act3 Transportation Progress EN – updated by Catherine on Jan 26

Note: *Suppressed owing to small numbers. 
Data source: Provincial cancer agencies and programs


Priority 5 Action 1: Integrate the full spectrum of information and support services to ensure people are fully supported throughout the cancer experience

Topic: Improving availability of information and support
Title of image: TBC
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

Brand new PE P5 Act1 Info EN added by Catherine on Jan 26

Data source: Patient Satisfaction Survey


Priority 5 Action 2: Address the limited and unequal access to palliative and end-of-life care across Canada

Topic: Improving access to quality end-of-life care
Title of image: Cumulative length of stay for cancer patients (overall) who were in or admitted to an acute care hospital 30 days prior to death across PE, for fiscal years 2015, 2017, and 2019
Median in 2019 is 12 days. Full table to follow.New PE P5 Act2 Length of Stay Overall EN updated Jan 26

Data source: Canadian Institute for Health Information (CIHI), Discharge Abstract Database (DAD)


Topic: Improving access to quality end-of-life care
Title of image: Cumulative length of stay for cancer patients (rural/remote) who were in or admitted to an acute care hospital 30 days prior to death across PE, for fiscal years 2015, 2017, and 2019
Median in 2019 is 15 days. Full table to follow.
New PE P5 Act2 Length of Stay Rural Remote EN updated Jan 26

Data source: Canadian Institute for Health Information (CIHI), Discharge Abstract Database (DAD)


Topic: Improving access to quality end-of-life care
Title of image: Cumulative length of stay for cancer patients (urban) who were in or admitted to an acute care hospital 30 days prior to death across PE, for fiscal years 2015, 2017, and 2019
Median in 2019 is 8 days. Full table to follow.

New PE P5 Act2 Length of Stay Urban EN updated Jan 26

Data source: Canadian Institute for Health Information (CIHI), Discharge Abstract Database (DAD)



Topic: Improving access to culturally safe palliative care
Title of image: Percentage of patients identified for palliative care that have advanced care planning/goals for care discussions initiated
Caveats/limitations: This measurement includes all patients enrolled in the PEI Integrated Palliative Care Program (IPCP). Patients receiving palliative care treatment but not enrolled in IPCP are not included at this time.
Overall: 100%
Data source: Patient Reported Outcome (PROs) provincial partners